Furthermore, when comparing ABCA1/G1-dependent cholesterol efflux between groups (calculated as the increase in efflux after subtracting baseline levels), CSF from AD patients and control individuals induced cholesterol efflux at similar levels (Fig. 1bright panel). This evidence concerns the gene ABCA1 and Alzheimer disease.